baber/WOPTO huggingface dataset:
Patent NZ-542537-A (NZ)
Title: Invoice and payment delivery via user accounts of telecommunications system
Inventor: MCNAMEE JOHN CHRISTOPHER
IPC: H04L12/56
Filed: 2000-05-11
Abstract: A document delivery system includes a plurality of user accounts each associated with a user and each including a message account and a financial account. Each message account can receive a user financial statement message indicative of a financial liability associated the user. A message retrieval element retrieves a financial statement message from the message account and a payment element facilitates payment towards the financial liability associated the user by transferring a financial commodity from the financial account associated with the user.
Patent NZ-544018-A (NZ)
Title: Asenapine for the treatment of schizophrenia in an overweight patient or a patient at risk for becoming overweight.
Inventor: TONNAER JEROEN ALPHONS DOROTHE
IPC: A61P25/18
Filed: 2004-06-09
Abstract: Disclosed is the use of an antipsychotic agent in the manufacture of a medicament for the treatment of schizophrenia in an overweight patient wherein the antipsychotic agent is asenapine.
Patent NZ-545234-A (NZ)
Title: Laryngeal mask
Inventor: BASKA KANAG
IPC: A61M16/04
Filed: 2004-07-30
Abstract: A device (10) for maintaining an airway in a patient comprises a mask (12), the mask having a resilient conformable peripheral portion (20, 22) shaped such that the mask (12) forms a seal with the larynx when the mask is positioned in the laryngo pharynx to thereby prevent ingress of extraneous fluids into the larynx, the peripheral portion (20, 22) of the mask defining at least one cavity (32, 34) for providing fluid communication to the oesophagus when the mask is inserted into the laryngo pharynx, and an airway tube (14) connected to or formed with the mask for passing gas to the larynx when the mask is properly inserted into the laryngo pharynx. The airway tube (14) preferably is curved as it leaves the mask. Fluid communication is provided between the nasopharynx and the oesophagus.
Patent NZ-551916-A (NZ)
Title: An instrument guard
Inventor: WINCH ROBERT
Filed: 2006-12-08
Abstract: A flexible guard for a musical instrument, the guard being formed from a flexible significantly heat insulating material and having a pair of sides sloping towards one another to give the guard a generally conical or generally pyramidal shape, the guard substantially encapsulating the instrument. The guard has a first end and a second end, the first end being open to allow the instrument to be removed from the guard when desired, the second end being opposite the first end and closed, the first end being substantially wider than the second end.
Patent NZ-552894-A (NZ)
Title: Aerated food products containing hydrophobin
Inventor: BERRY MARK JOHN
IPC: A23P30/40
Filed: 2005-06-27
Abstract: Disclosed is an aerated food product (such as a chilled or frozen food product) comprising at least 0.001 wt% and less than 1 wt% hydrophobin in isolated form. Also disclosed is a method for improving shape retention and/or rigidity in an aerated food product which method comprises adding hydrophobin to the food product prior to and/or during aeration of the product.
Patent NZ-553010-A (NZ)
Title: Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
Inventor: BULLOCK GILLIAN ROSEMARY
IPC: A61K45/00
Filed: 1999-12-22
Abstract: Disclosed is a tablet comprising valsartan in free form and more than 30% of microcrystalline cellulose by weight based on the total weight of the core components of said form.
Patent NZ-553235-A (NZ)
Title: Culturing human pluripotent stem cells
Inventor: THOMSON JAMES A
IPC: C12N5/02
Filed: 2005-09-08
Abstract: Disclosed is a method for initiating a new cultured line of human pluripotent stem cells without the use of feeder cells or conditioned medium, the method comprising the step of plating cells from a blastocyst onto a matrix in a medium including albumin, minerals, vitamins, amino acids, glucose, a fibroblast growth factor, gamma amino butyric acid, pipecolic acid, lithium lipids, a transferrin or a transferrin substitute and insulin or an insulin substitute in sufficient amounts to originate and maintain a new proliferating stem cell line in an undifferentiated state.
Patent NZ-553597-A (NZ)
Title: Watercraft comprising a kite-like element
Inventor: WRAGE STEPHAN
IPC: B63H9/06
Filed: 2005-09-05
Abstract: A watercraft having a kite-like element for propelling the watercraft, wherein the kite-like element is connected to the watercraft by a hawser, is disclosed. The kite-like element has adjusting devices and a power generating device, where the power generating device generates power when there is a change in the tensile force exerted on the hawser.
Patent NZ-565020-A (NZ)
Title: Solid dosage forms of valsartan and amlodipine and method of making the same
Inventor: JOSHI YATINDRA
IPC: A61K9/28
Filed: 2006-08-15
Abstract: Disclosed is a solid dosage form of valsartan comprising: valsartan; amlodipine; and pharmaceutically acceptable additives suitable for the preparation of solid dosage forms of valsartan, wherein the amlodipine is provided in the form of amlodipine besilate; and the amount of valsartan/free amlodipine present in the solid dosage form dosage is selected from 80/2.5 mg, 80/5 mg, 160/5 mg, 160/10 mg, 320/5 mg, and 320/10 mg. Also disclosed is a method of making said solid dosage form of valsartan comprising the steps of: (a) blending valsartan, amlodipine and pharmaceutically acceptable additives to form a blended material; (b) sieving the blended material to form a sieved material; (c) blending the sieved material to form a blended/sieved material; (d) compacting the blended/sieved material to form a compacted material; (e) milling the compacted material to form a milled material; (f) blending the milled material to form blended/milled material; and (g) compressing the blended/milled material to form a monolayer solid dosage form and the use of said solid dosage form for the manufacture of a medicament for treating hypertension, congestive heart failure, angina, myocardial infarction, arteriosclerosis, diabetic nephropathy, diabetic cardiac myopathy, renal insufficiency, peripheral vascular disease, stroke, left ventricular hypertrophy, cognitive dysfunction, headache, or chronic heart failure.
Patent NZ-584482-A (NZ)
Title: Goundwater monitoring system with usage optimisation algorithms
Inventor: KRAM MARK
IPC: G06F19/00
Filed: 2008-09-08
Abstract: A real-time automated system for resource usage optimization is disclosed, in particular for water well monitoring and river water level assurance. The automated system includes a number of automatically controlled sensor suites, each suite having multiple sensors (10); a computer system (18) having spatial data processing algorithms for processing data selected from a set of locations of sensor suites; a control module (24) incorporating an interactive logic, operating in conjunction with the spatial data processing algorithms and receiving as an input an objective function set for the use of a resource and constraint sets including transmissivity and storativity associated with a source and intervening geological formations; means for receiving data monitored by the sensor suites (14); means comparing the received data to the constraint sets (28); means responsive to the comparing means for providing the sensor suite input data to a constraint sets calculator for update of the constraints set for remodelling of interactive logic calculations; means for determining the fraction of the effect of each user from multiple users on the resource and calculating total use from multiple users simultaneously; means for estimating maximum use rate for each user of the multiple users and, means for creating a report/alarm for action upon impact to any of the elements of the objective function set.
Patent NZ-586735-A (NZ)
Title: Aminotriazole derivatives as alx agonists
Inventor: BUR DANIEL
IPC: A61K31/4192
Filed: 2008-12-17
Abstract: Disclosed is a compound of the formula (I), e.g. 5-phenyl-oxazole-4-carboxylic acid [2-(5-acetyl-furan-2-ylmethyl)-2H-[1,2,3]triazol-4-yl]amide wherein the variables are defined in the specification or a salt of such a compound for the prevention or treatment of a disease selected from inflammatory diseases, obstructive airway diseases, allergic conditions, HIV-mediated retroviral infections, cardiovascular disorders, neuroinflammation, neurological disorders, pain, prion-5 mediated diseases and amyloid-mediated disorders; and for the modulation of immune responses.
Patent NZ-588084-A (NZ)
Title: POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF
Inventor: ALMARIO GARCIA ANTONIO
IPC: A61P19/00
Filed: 2009-03-20
Abstract: Disclosed are 2-heteroaryl-6-phenyl-imidazo[1,2-a]pyridine derivatives as represented by the general formula (I), wherein: R1 is heteroaryl or a heterocyclic group each of which may be optionally substituted; and wherein the remaining substituents are as defined herein. Representative compounds include those such as { 3-[2-(5-methylisoxazol-4-yl)imidazo[1,2-a]pyridin-6-yl]phenyl} methanol, [3-[2-(pyridin-4-yl)imidazo[1,2-a]pyridin-6-yl]phenyl]methanol and the hydrochloride thereof, 6-[6-(3-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]-3,4-dihydro-1H-quinolin-2-one and the hydrochloride thereof, 2-(5-bromo-2,3-dihydrobenzofuran-7-yl)-6-(3-tertbutoxymethylphenyl)imidazo[1,2-a]pyridine, [2-(2-furan-3-ylimidazo[1,2-a]pyridin-6-yl)phenyl]methanol hydrochloride, { 3-[2-(1H-indol-4-yl)imidazo[1,2-a]pyridin-6-yl]phenyl} methanol and the hydrochloride thereof and [3-[2-(thien-2-yl)imidazo[1,2-a]pyridin-6-yl]phenyl]methanol. Further disclosed is a pharmaceutical composition, which comprises a compound of formula (I) as defined above or a pharmaceutically acceptable salt thereof and also at least one pharmaceutically acceptable excipient, for the treatment and prevention of neurodegenerative diseases, cerebral traumas, epilepsy, psychiatric diseases, inflammatory diseases, osteoporosis and / or cancers.
Patent NZ-589979-A (NZ)
Title: Supply of liquid coolant to the drill using the pressurised air flow that also powers the drill turbine
Inventor: VARNES DEWAYNE L
IPC: A61C17/028
Filed: 2009-07-30
Abstract: 589979 A dental fluid delivery system for use with a dental drill is disclosed. The delivery system comprises a coolant water supply unit (51), a drive air line (52), a water line (53) and a coolant mist air controller (80). The coolant water supply unit (51) includes a controller (10) and a water container (11), the water controller (10) having a drive air inlet (43), a water inlet communicatively connected to the water container, a drive air outlet (46) and a water outlet (31). A first bore within the controller (10) permits passage of drive air from the air inlet (43) to the air outlet (46) and is controller with a knob (55). A second bore extending from the first bore permits drive air into the water container (11). A third bore extending from the water container (11) permits passage of liquid from the container (11) to the water outlet (31), and fourth and fifth bores separated by a flexible membrane selectively controls communication between the fourth bore and an exhaust vent. The drive air line (52) is connected to the drive air outlet (46) of the water supply unit (51) and the water line (53) is connected to the water outlet (31) of the water supply unit (51). The coolant mist air controller (80) connects to a dental drill (50), the mist air controller (80) having a drive air inlet (99), a drive air outlet, a water inlet (84), a water outlet, and a mist air outlet.:
Patent NZ-592071-A (NZ)
Title: Device for reducing the preparation time in ovens having a rotary basket by introducing ventilating air near the circulating fan shaft
Inventor: HANSSON BENGT
IPC: A47J36/38
Filed: 2009-08-21
Abstract: 592071 A convection oven (30) for preparation of food is disclosed. The oven comprises an oven compartment (3) having a rotary preparation basket (17), a circulating fan (4), at least one heating element (7) and at least one air inlet (1) for cold ventilating air. The inlet is placed in close vicinity to a shaft (5) of the fan and to a gap (22) between the circulating fan (4) and a wall of the oven compartment. Dry ventilating air can flow into the gap (22) and is centrifugally discharged and mixed into the circulating heat transport medium at a periphery of the circulating fan (4) which reduces preparation time of the food product in the preparation basket (17).
Patent NZ-592742-A (NZ)
Title: Implant systems and methods for treating obstructive sleep apnea
Inventor: JACOBS JOHN R
IPC: A61F2/02
Filed: 2009-11-20
Abstract: 592742 A system for treating obstructive sleep apnea. The system includes a substantially flat, planar first implant (1200) adapted for implantation in an inframandibular region and having at least one aperture therethrough, the first implant further including a substantially flat, planar cover portion (1203), and a substantially flat, planar base portion (1204) coupled to the cover portion around a peripheral edge (1208) so as to form a pouch (1206) therebetween, a substantially flat, planar anchor element (1201) being positioned within the pouch between the cover portion and base portion, the aperture extending through the cover portion, base portion and anchor element; and a ribbon-like element having first and second ends and a substantially uniform, non-circular cross section along its length. The ribbon-like element is adapted for implantation in a tongue with the first and second ends extending through the at least one aperture in the first implant for coupling the ribbon-like element with the first implant.
Patent NZ-594561-A (NZ)
Title: A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
Inventor: STARRETT JR JOHN E
IPC: C07D237/02
Filed: 2009-03-19
Abstract: Patent No. 594561 Disclosed the use of (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide in the preparation of a medicament for the treatment of head trauma, traumatic brain injury, and/or dementia pugilistica.
Patent NZ-597036-A (NZ)
Title: Methods of making vertical junction field effect transistors and bipolar junction transistors without ion implantation and devices made therewith
Inventor: CHENG LIN
IPC: H01L21/311
Filed: 2010-06-18
Abstract: 597036 Disclosed is a method of making a semiconductor device from a stack of semiconductors layers. The stack of layers is arranged to include an n-type source layer above an n-type isolation layer; the n-type isolation layer is above a p-type buried gate layer; the p-type buried gate layer is above an n-type drift layer; and the n-type drift layer is above an n-type substrate. The method is performed by: forming a first etch mask on an n-type source layer; selectively etching through the source and isolation layers and into the buried gate layer using the first etch mask to form raised source regions having upper surfaces and sidewalls, the etching exposing a portion of the buried gate layer adjacent to the raised source regions; positioning a second etch mask on the exposed portion of the buried gate layer in a peripheral region; selectively etching through the buried gate layer using the first and second etch masks to expose n-type drift layer adjacent the raised source regions thereby defining a region of p-type material in the peripheral region. The region of p-type material has an upper surface and sidewalls, and the p-type buried gate layer in the raised source regions is in contact with the region of p-type material defined in the peripheral region; removing the first and second etch masks; epitaxially growing an n-type channel layer on the upper surfaces and sidewalls of the raised source regions; selectively etching the n-type channel layer to expose at least the source layer on the upper surfaces of the raised source regions; epitaxially growing a p-type gate layer on the n-type channel layer on the sidewalls of the raised source regions; forming ohmic contacts on the upper surfaces of the raised source regions, on the epitaxially grown p-type gate layer adjacent the raised source regions, and on the epitaxially grown p-type gate layer in the peripheral region; depositing etch mask material on the ohmic contact material on the epitaxially grown p-type gate layer and on the ohmic contact material on the upper surfaces of the raised source regions such that epitaxially grown channel and gate layer on the sidewalls of the raised source regions is not masked; planarising with a planarising material; etching the planarising material to remove the epitaxially grown p-type gate and n-type channel layers from an upper portion of the sidewalls of the raised source regions; and removing at least some of the planarising material and the etch mask material. Semiconductor devices formed by this method are also disclosed, as well as circuits containing the semiconductor devices.
Patent NZ-598483-A (NZ)
Title: Drug cores for sustained release of therapeutic agents
Inventor: UTKHEDE DEEPANK
IPC: A61F2/02
Filed: 2008-09-05
Abstract: A punctal plug implant configured to be disposed within the lacrimal canaliculus of an eye. The implant contains a drug core that comprises a silicone matrix containing monodispersed liquid latanoprost inclusions having a uniform size to form a solid drug matrix, and the latanoporst is at least 20 percent (by weight) of the drug core.
Patent NZ-600194-A (NZ)
Title: Grid Members for a Suspended Ceiling and Methods of Making Same
Inventor: FIELD GRAHAM KEITH
IPC: E04B9/06
Filed: 2009-01-07
Abstract: 600194 The runner has two parallel web portions and two flange portions to form a general shape of an inverted tee. A capping portion is on the underside of at least one flange portion. At least two longitudinally extending parallel channels integrally formed on each of the web portions is adapted to increase the torsional resistance of the runner.
Patent NZ-601843-A (NZ)
Title: Monoclonal anti beta amyloid antibody
Inventor: WATTS RYAN
IPC: A61K39/395
Filed: 2008-06-12
Abstract: NZ 601843 Disclosed is an antibody or an epitope-binding fragment thereof capable of specifically binding beta amyloid, wherein the antibody or the epitope-binding fragment thereof is as defined in the complete specification. Also disclosed are methods of diagnosis and treatment of amyloidosis utilising the disclosed antibody.
Patent NZ-603313-A (NZ)
Title: A gripper, a milking robot and a milking arrangement
Inventor: AXELSSON THOMAS
IPC: A01J5/017
Filed: 2011-06-10
Abstract: 603313 A gripper for a milking robot has a proximal end and a distal end and is attached to the robot arm or link at the proximal end 19. The gripper has an extension plane and a longitudinal centre axis (x4), about which the gripper can be rotated on the end of the robot arm, extending in the extension plane through the proximal end and the distal end. The longitudinal centre axis x4 divides the gripper into a primary side (10a) and a secondary side (10b). The gripper has four separate gripping recesses (11 - 14), each being configured to grip a respective teatcup. The gripping recesses are asymmetrically positioned with respect to the longitudinal centre axis, at least three of the gripping recesses being mainly located on the primary side.
Patent NZ-609505-A (NZ)
Title: Method for producing 3,4-disubstituted pyrrolidine derivative
Inventor: NAGAO MUNEKI
IPC: C07B53/00
Filed: 2011-10-24
Abstract: Provided are methods for producing an anti-4-hydroxypyrrolidine-3-carboxamide derivative or an enantiomer thereof, of general formula (II), where the variables are as described in the specification. The methods for producing the compounds are characterised by the asymmetric hydrogenation of a 4-oxopyrrolidine-3-carboxylic acid amide derivative, of general formula (I), where the variables are as described in the specification, using an optically active catalyst. Further provided are methods of preparing compounds of the formulas (III), (IV) and (V),where their variables are as described in the specification, used in the production of the anti-4-hydroxypyrrolidine-3-carboxamide derivatives.
Patent NZ-621454-A (NZ)
Title: A collaboration computer system
Inventor: PERKINS GRAEME
IPC: G06Q10/06
Filed: 2012-08-23
Abstract: Disclosed is a collaboration computer system including a database system (306, 310) and a processing system (302, 304, 312, 314) for communicating with the database system. The database system maintains (i) user data representing users; (ii) model data representing process models of respective processes and defining steps and associated users of each process; (iii) touch point data representing connections between steps of different independent processes; and (iv) state data associated with steps of instances of the processes. The processing system includes a user module to associate users with respective user data; a model module to generate user interfaces for users to create the process models and generate the model data, and associate processes to users, independently of other users; and an instance module to generate and operate instances of the processes based on the models and monitor state changes of the steps in parallel based on the state data, and generate notification message data based on the touch point data on state change of a connected step.
Patent NZ-625848-A (NZ)
Title: Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
Inventor: POTTIER AGNÈS
IPC: A61P35/00
Filed: 2012-12-17
Abstract: A nanoparticle comprises a metallic material at least partially covered or embedded in a hafnium oxide material whereat least 80% of the metallic material is protected from any interaction with a biological material by the hafnium oxide material. A composition containing the nanoparticle is disclosed. The nanoparticle and/or composition can be used as a diagnostic agent when the nanoparticle is exposed to radiation or can be suitable for use as a therapeutic agent in the treatment of cancer.
Patent NZ-707636-A (NZ)
Title: Ingenol-derived compounds that can be used for treating cancer
Inventor: PIANOWSKI LUIZ FRANCISCO
IPC: A61K31/216
Filed: 2013-10-31
Abstract: The present invention relates to novel ingenol-derived compounds for treating cancer. In other aspects, the invention relates to a pharmaceutical composition, drug, cancer treatment method and dosage form.
Patent NZ-732413-A (NZ)
Title: Method for obtaining information about a farm animal
Inventor: AUER WOLFGANG
IPC: A01K29/00
Filed: 2015-12-03
Abstract: The invention relates to a method for obtaining information about a farm animal, wherein a device (a) is attached to the head region of an animal, said device containing at least one acceleration sensor by means of which recurring acceleration data is measured, wherein the acceleration data is evaluated using automatic data processing means, and, as an outcome of the evaluation, is indicative of the activities and/or conditions of the animal. The acquired acceleration data is evaluated in order to detect the swallowing processes carried out by the animal.